close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis  

What's this?
Dollar7823Point52
Implied share price

Buy Undervalued by 42721.7%

5% margin of safety What's this?

EV / Revenue
Use Average
PLX
Protalix BioTherapeutics Inc.
KUN
China Shenghuo Pharmaceutical Hldg, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
AMGN
Amgen, Inc.
Change
SNY
Sanofi SA (ADR)
Change
21251.16 48.12 27840.41 12.7 7.23 2.03
All amounts in millions
from last financial year
         
Implied Share Price $7823.52 $47685.92 $157784.84 $521742.51 $535908.30
Market Cap 1,701 1,229,412 137,726 122,216 121,391
Net Debt -52 20 4,504 12,727 6,333
Enterprise Value (EV) 1,656 1,229,432 142,230 134,943 67,548
Revenue 34 44 11,201 18,676 33,306
Balance Sheet          
Total Assets 78 58 22,496 66,125 96,055
Total Liabilities 82 56 11,127 44,029 39,151
Shareholders Equity -3 2 11,369 22,096 56,904.0

Where are the EBIT and EBITDA figures?

Certain companies and those in specific industries (for example insurance) do not report financial results at the EBIT or EBITDA line. For these companies where Valuecruncher does not have EBIT or EBITDA numbers we exclude the valuation metrics driven by these figures. Valuecruncher makes our other valuation metrics available for these companies.

To learn more about comparison analysis, please read our guide to comparison analysis

Comments

No comments yet. Login to comment.